GSK Announces Submission of Albiglutide Bla to the Us Fda for the Treatment of Type 2 Diabetes
GlaxoSmithKline plc today announced a regulatory submission to the US Food and Drug Administration for albiglutide, an investigational once-weekly treatment for adult patients with type 2 diabetes.
Join the discussion below, or Read more at Drugs.com.
#1 Jan 15, 2013
Learn more about Albiglutide at http://www.rxwiki.com/albiglutide
Add your comments below
|Cost of EpiPen: Senators' daughters call for ac...||Fri||californio||6|
|Mylan promotes Bresch to president (Jul '09)||Aug 24||Benny||3|
|Officials: Zika won't hurt South Florida touris...||Aug 23||WeTheSheeple||28|
|US Centers for Disease Control and Prevention -...||Aug 23||Rainbow Kid||3|
|Jackson Laboratory to get nearly $12M for addic...||Aug 14||s||1|
|Florida governor criticizes Washington for lagg...||Aug 8||Washington Sugs Now||2|
|Johnson & Johnson to cut about 3,000 jobs (Jan '16)||Aug 6||Dirk||2|
Find what you want!
Search Biotech Forum Now
Copyright © 2016 Topix LLC